SIBO - Small Intestinal Bacterial Overgrowth
  • Welcome
  • About SIBO
    • Overview
    • Symptoms
    • Associated Diseases
    • Testing
  • Treatment
    • Overview
    • Antibiotics
    • Herbal Antibiotics
    • Elemental Formula
    • Diet
    • Prevention of Relapse
  • Learning More
  • Studies
    • 2022
    • 2021
    • 2020
    • 2019
    • 2018
    • 2017
    • 2016
    • 2015
    • 2014
    • 2013
    • 2012
    • 2011
    • 2009
    • 1990's
    • 1980's
  • Resources
    • Finding a Doctor
    • Testing
    • Handouts
    • Books
    • Cookbooks
    • Diet/Recipe Websites
    • Apps
    • Discussion Groups
    • Podcasts
    • MMC Videos
    • Elemental Diet Videos
  • Contact
    • About Dr. Siebecker
    • Skype Consultations

2011 Research Articles

By Cedars-Sinai Team/ Dr Pimentel:
  • History of Tonsillectomy is Associated with IBS. - letter to the editor
  • Effects of rifaximin treatment and retreatment in nonconstipated IBS subjects.
  • Efficacy of the glucagon-like peptide-1 agonist exenatide in the treatment of short bowel syndrome.
  • Acute and Chronic Histological Changes of the Small Bowel Secondary to C. jejuni Infection in a Rat Model for Post-Infectious IBS.
  • Inflammation and microflora.
  • Importance of Diarrhea in Evaluating Constipation in Irritable Bowel Syndrome Clinical Studies.
  • Methane on breath testing is associated with constipation: a systematic review and meta-analysis.
  • Relationships among the lactulose breath test, intestinal gas volume, and gastrointestinal symptoms in patients with irritable bowel syndrome.
  • Antibiotic prophylaxis prevents the development of a post-infectious phenotype in a new rat model of post-infectious IBS.
  • Rifaximin therapy for patients with irritable bowel syndrome without constipation.
  • Factor analysis demonstrates a symptom cluster related to methane and non-methane production in irritable bowel syndrome.

By Dr Weinstock (& associates):
  • Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome.
  • Chronic prostatitis and small intestinal bacterial overgrowth: effect of rifaximin.
  • Restless legs syndrome is associated with irritable bowel syndrome and small intestinal bacterial overgrowth.
  • Rosacea in Crohn's Disease: Effect of Rifaximin.

By Rome, Italy team:
  • Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.
  • Prevalence of small intestinal bacterial overgrowth in Parkinson's disease.

Others:
  • Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth.
  • Gastrointestinal transit in patients with systemic sclerosis.
  • Small intestinal bacterial overgrowth and Helicobacter pylori: can they be cause of thrombocytopenia in patients with chronic liver disease?
  • When to reconsider the diagnosis of irritable bowel syndrome.
  • Probable interaction between warfarin and rifaximin in a patient treated for small intestine bacterial overgrowth.
  • Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
  • Small intestinal bacterial overgrowth (SIBO) in irritable bowel syndrome: frequency and predictors.
  • Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.
  • Clinical predictors of small intestinal bacterial overgrowth by duodenal aspirate culture.
  • The role of small intestinal bacterial overgrowth in postgastrectomy patients.
  • Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure.
  • Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS.
  • Small intestinal bacterial overgrowth in nonalcoholic steatohepatitis: association with toll-like receptor 4 expression and plasma levels of interleukin 8.

In Spanish:
  • [Comparative clinical efficacy of a probiotic vs. an antibiotic in the treatment of patients with intestinal bacterial overgrowth and chronic abdominal functional distension: a pilot study].

In Russian:
  • [Rationale for the allocation of clinical variants of the postcholecystectomical syndrome associated with bacterial overgrowth in the small intestine].
  • [Diagnosis and treatment of the bacterial overgrowth syndrome in the small intestine].
  • [Enterosan--perspective medications for patients with postinfection irritable bowel syndrome].
  • [Rifaximin application in the overgrowth bacterial syndrome in the small intestine in patients after cholecystectomy].
  • [Treatment of disbacteriosis of gastroduodenal mucous microflora in mucosa inflammation, ulcer and erosion].
15% Off All Supplements at Fullscript
If you value this website, consider supporting the free information provided on siboinfo.com and it's newsletter, which helps SIBO sufferers world wide.


Site author:  Dr Allison Siebecker
Powered by Create your own unique website with customizable templates.